Google SSO gives you the quickest path into the IIPLA newsroom, your reading access, and member-level continuity across articles. The full login page is still available if you prefer another option.
USTR's annual review singles out Vietnam for heightened scrutiny, raising possibility of a Section 301 trade investigation.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
India, May 02 : India has once again been placed on the United States Trade Representative’s (USTR) “Priority Watch List” in its latest annual review of intellectual property rights (IPR) protection and enforcement. The designation places India among six countries identified by the US as having significant concerns re…
The 2026 Special 301 Report highlights Thailand’s proactive enforcement and legislative reforms, though online piracy and patent backlogs remain concerns The 2026 Special 301 Report highlights Thailand’s proactive enforcement and legislative reforms, though online piracy and patent backlogs remain concerns.
The New York State Bar Association has opened registration for its 2025 Fall Intellectual Property Meeting, featuring panels on evolving brand licensing practices, advertising law challenges, and ethical considerations in AI use for legal services. The event, co-sponsored by Akerman LLP, will provide 3.0 MCLE credits…
Zydus Lifesciences Limited has finalized a comprehensive settlement with Astellas Pharma Inc., ending all US patent disputes over the bladder drug Myrbetriq (Mirabegron). The agreement requires Zydus to pay $120 million plus ongoing licensing fees until September 2027, allowing the company to continue marketing its ge…
Washington urges tougher enforcement against intellectual property violations by smaller operators The United States has kept Thailand on its trade watch list for another year, urging stricter enforcement against online piracy platforms and targeting of more small-scale violators of intellectual property.
The United States has once again placed India on its Priority Watch List in the 2024 Special 301 Report, citing ongoing concerns over India's pharmaceutical patent policies, data protection, and enforcement mechanisms. The move underscores a longstanding divide between the two nations over balancing intellectual prope…